Another Sucess In Alzheimer’s Disease
May 03, 2023 at 10:50 AM EDT
Eli Lily reported a successful phase III trial of donanemab in Alzheimer’s Disease. How does it differentiate from lecanemab and what does it mean for beta-amyloid treatments?
